Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
Journal of Psychiatry and Neuroscience (2012) Vol. 37, Iss. 6, pp. 407-415
Open Access | Times Cited: 55

Showing 26-50 of 55 citing articles:

Antidiabetic-drug combination treatment for glucose intolerance in adult female rats treated acutely with olanzapine
Heidi N. Boyda, Ric M. Procyshyn, Yahya I. Asiri, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2013) Vol. 48, pp. 170-176
Closed Access | Times Cited: 22
An Evaluation of the Effects of the Novel Antipsychotic Drug Lurasidone on Glucose Tolerance and Insulin Resistance: A Comparison with Olanzapine
Claire Wu, Jessica W. Y. Yuen, Heidi N. Boyda, et al.
PLoS ONE (2014) Vol. 9, Iss. 9, pp. e107116-e107116
Open Access | Times Cited: 20
Female mice are protected against acute olanzapine-induced hyperglycemia
Kyle D. Medak, Logan K. Townsend, Margaret Hahn, et al.
Psychoneuroendocrinology (2019) Vol. 110, pp. 104413-104413
Closed Access | Times Cited: 19
Antipsychotic polypharmacy increases metabolic dysregulation in female rats.
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
Experimental and Clinical Psychopharmacology (2013) Vol. 21, Iss. 2, pp. 164-171
Closed Access | Times Cited: 18
Improving Metabolic and Cardiovascular Health at an Early Psychosis Intervention Program in Vancouver, Canada
Diane Fredrikson, Heidi N. Boyda, Lurdes Tse, et al.
Frontiers in Psychiatry (2014) Vol. 5
Open Access | Times Cited: 17
GLP1 receptor agonism protects against acute olanzapine-induced hyperglycemia
Kyle D. Medak, Hesham Shamshoum, Willem T. Peppler, et al.
AJP Endocrinology and Metabolism (2020) Vol. 319, Iss. 6, pp. E1101-E1111
Closed Access | Times Cited: 15
Peripheral mechanisms of acute olanzapine induced metabolic dysfunction: A review of in vivo models and treatment approaches
Hesham Shamshoum, Kyle D. Medak, David C. Wright
Behavioural Brain Research (2020) Vol. 400, pp. 113049-113049
Closed Access | Times Cited: 15
Fasting or the short‐term consumption of a ketogenic diet protects against antipsychotic‐induced hyperglycaemia in mice
Hesham Shamshoum, Kyle D. Medak, Greg L. McKie, et al.
The Journal of Physiology (2022) Vol. 600, Iss. 11, pp. 2713-2728
Closed Access | Times Cited: 9
Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production
Elodie M. Girault, Ewout Foppen, Mariëtte T. Ackermans, et al.
Brain Research (2013) Vol. 1527, pp. 238-245
Closed Access | Times Cited: 15
Coadministration of metformin prevents olanzapine-induced metabolic dysfunction and regulates the gut-liver axis in rats
Chao Luo, Xu Wang, Hanxue Huang, et al.
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 239-248
Closed Access | Times Cited: 14
Pharmacological management of diabetes in severe mental illness: a comprehensive clinical review of efficacy, safety and tolerability
John Lally, Aonghus O’ Loughlin, Brendon Stubbs, et al.
Expert Review of Clinical Pharmacology (2018) Vol. 11, Iss. 4, pp. 411-424
Open Access | Times Cited: 13
Cardiovascular effects of acute treatment with the antipsychotic drug olanzapine in rats
Joanne Y.T. Leung, Catherine C.Y. Pang, Ric M. Procyshyn, et al.
Vascular Pharmacology (2014) Vol. 62, Iss. 3, pp. 143-149
Closed Access | Times Cited: 12
A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models
Jessica W. Y. Yuen, Che Hsuan David Wu, Catherine K. Wang, et al.
Neuropharmacology (2019) Vol. 175, pp. 107717-107717
Closed Access | Times Cited: 11
Metformin attenuates antipsychotic-induced metabolic dysfunctions in MK801-induced schizophrenia-like rats
Chao Luo, Xu Wang, Xiao‐Yuan Mao, et al.
Psychopharmacology (2020) Vol. 237, Iss. 8, pp. 2257-2277
Closed Access | Times Cited: 11
A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models
Heidi N. Boyda, Ric M. Procyshyn, Lurdes Tse, et al.
PLoS ONE (2021) Vol. 16, Iss. 1, pp. e0246211-e0246211
Open Access | Times Cited: 9
Interaction of clozapine with metformin in a schizophrenia rat model
Gyöngyi Horváth, Gyöngyi Kis, Gabriella Kékesi, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 9
Olanzapine-induced insulin resistance may occur via attenuation of central KATP channel-activation
Chantel Kowalchuk, L Castellani, Pruntha Kanagsundaram, et al.
Schizophrenia Research (2021) Vol. 228, pp. 112-117
Closed Access | Times Cited: 8
A retrospective study of antipsychotic drug switching in a pediatric population
David Linton, Ric M. Procyshyn, Dean Elbe, et al.
BMC Psychiatry (2013) Vol. 13, Iss. 1
Open Access | Times Cited: 8
Acute Metabolic Effects of Olanzapine Depend on Dose and Injection Site
Candice M. Klingerman, Michelle E. Stipanovic, A. Hajnal, et al.
Dose-Response (2015) Vol. 13, Iss. 4
Open Access | Times Cited: 7
A Tetra-Primer Amplification Refractory System Technique for the Cost-Effective and Novel Genotyping of Eight Single-Nucleotide Polymorphisms of the Catechol-O-Methyltransferase Gene
Cathy K. Wang, Ana Aleksić, Michael S. Xu, et al.
Genetic Testing and Molecular Biomarkers (2016) Vol. 20, Iss. 8, pp. 465-470
Closed Access | Times Cited: 5
Voluntary physical activity protects against olanzapine-induced hyperglycemia
Hesham Shamshoum, Greg L. McKie, Kyle D. Medak, et al.
Journal of Applied Physiology (2020) Vol. 130, Iss. 2, pp. 466-478
Closed Access | Times Cited: 5
Empagliflozin Effectively Attenuates Olanzapine-Induced Body Weight Gain in Female Wistar Rats
Ghulam Md Ashraf, Badrah S. Alghamdi, Fahad S. Alshehri, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 4
A ganglionic blocker and adrenoceptor ligands modify clozapine-induced insulin resistance
Jessica W. Y. Yuen, Claire Wu, Cathy K. Wang, et al.
Psychoneuroendocrinology (2021) Vol. 129, pp. 105257-105257
Closed Access | Times Cited: 4
Olanzapine as a cause of urinary incontinence: a case report.
Mobolaji Usman Dada, Lateef Olutoyin Oluwole, Patrick Temi Adegun, et al.
PubMed (2012)
Closed Access | Times Cited: 3
Metabolic adverse effects of antipsychotics: the state of the problem and management options
A. V. Balashova, Diana V. Mamleeva, Л. В. Мачехина, et al.
Obesity and metabolism (2023) Vol. 19, Iss. 4, pp. 431-441
Open Access | Times Cited: 1

Scroll to top